Sage Journals: Discover world-class research

Free access

Research article

First published 2012

Survey of KRAS,BRAF and PIK3CA mutational status in 209 consecutive Italian colorectal cancer patients

Cristina Bozzao, Dora Varvara, Marilidia Piglionica [...]

The International Journal of Biological Markers

Retricted access

Case report

First published 2019-9

Undifferentiated Sarcoma as Intermediate Step in Rhabdomyosarcomatous Transformation of a Metastatic Malignant Melanoma Resistant to Anti-BRAF Therapy: A Phenomenon Associated With Significant Diagnostic and Therapeutic Pitfalls

Tien Anh N. Tran

International Journal of Surgical Pathology

Retricted access

Case report

First published 2021-6

Alternative use of BRAF inhibitors in patients with metastatic melanoma unable to swallow pills

M Darrigade Fleury, Marie Masson Regnault, S Cales [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2012-1

Combined mutational analysis of KRAS,NRAS and BRAF genes in Indian patients with colorectal carcinoma

Sarita B. Bagadi, Meera Sanghvi, Sudish B. Nair [...]

The International Journal of Biological Markers

Open access

Review article

First published 2022

Encorafenib plus cetuximab for the treatment of BRAF-V600E -mutated metastatic colorectal cancer

Javier Ros, Nadia Saoudi, Iosune Baraibar [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2021-7

EGFR Overexpression and Sequence Analysis of KRAS,BRAF,and EGFR Mutation Hot Spots in Canine Intestinal Adenocarcinoma

Seung-Hee Cho, Byung-Joon Seung, Soo-Hyeon Kim [...]

Veterinary Pathology

Retricted access

Case report

First published 2024-9

Concomitant Non-V600E BRAF and KRAS Mutations in Colorectal Carcinoma by Next-Generation Sequencing: A Distinct Subtype

Pallavi Srivastava, Sridhar Mishra, Saumya Shukla [...]

International Journal of Surgical Pathology

Retricted access

Research article

First published 2019-04

Combination Treatment with the BRAF V600E Inhibitor Vemurafenib and the BH3 Mimetic Navitoclax for BRAF -Mutant Thyroid Carcinoma

Ju Hye Jeong, Ji Min Oh, Shin Young Jeong [...]

Thyroid®

Open access

Case report

First published 2021

Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases

Christopher C. Hemond, Rohit Bakshi, Shahamat Tauhid [...]

Journal of Investigative Medicine High Impact Case Reports

Retricted access

Review article

First published 2021-11

Effect of KRAS and BRAF mutations in metastatic colorectal cancer patients: A systematic review and meta-analysis based on tumor sidedness and KRAS subtypes

Khadijeh Saravani, Morteza Salarzaei, Fateme Parooie

Human Antibodies

Search results